{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:41:49Z","timestamp":1792489309745,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"crossref","award":["JDZX2012051"],"award-info":[{"award-number":["JDZX2012051"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bjid.2015.12.006","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T21:14:46Z","timestamp":1455398086000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China"],"prefix":"10.1016","volume":"20","author":[{"given":"Youyun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2015.12.006_bib0155","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2015.12.006_bib0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2015.12.006_bib0165","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.bjid.2015.12.006_bib0170","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2015.12.006_bib0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12072-008-9048-3","article-title":"Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure","volume":"2","author":"Locarnini","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.bjid.2015.12.006_bib0180","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2012.04.037","article-title":"Long-term continuous entecavir therapy in nucleos(t)ide-na\u00efve chronic hepatitis B patients","volume":"57","author":"Ono","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2015.12.006_bib0185","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bjid.2015.12.006_bib0190","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jhep.2008.12.005","article-title":"Genetic variability of hepatitis B virus and response to antiviral treatments: searching for a bigger picture","volume":"50","author":"Yuen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2015.12.006_bib0195","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.antiviral.2011.08.013","article-title":"Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naive to antiviral drugs","volume":"92","author":"Salpini","year":"2011","journal-title":"Antivir Res"},{"key":"10.1016\/j.bjid.2015.12.006_bib0200","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1413-8670(12)70319-7","article-title":"YMDD motif mutations in chronic hepatitis B patients: a multi-center study","volume":"16","author":"Tan","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2015.12.006_bib0205","first-page":"e6712","article-title":"Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-na\u00efve chronic HBV patients","volume":"13","author":"Majabadi","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1016\/j.bjid.2015.12.006_bib0210","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cgh.2013.11.036","article-title":"Mutations in HBV DNA polymerase associated with nucleotide resistance are rare in treatment-na\u00efve patients","volume":"12","author":"Vutien","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2015.12.006_bib0215","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jgh.12831","article-title":"Incidence of natural resistance mutations in na\u00efve chronic hepatitis B patients: a systematic review and meta-analysis","volume":"30","author":"Zhang","year":"2015","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2015.12.006_bib0220","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2006.01.001","article-title":"HBV drug resistance: mechanisms, detection and interpretation","volume":"44","author":"Shaw","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2015.12.006_bib0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.21698","article-title":"Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management","volume":"46","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2015.12.006_bib0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3851\/IMP1619","article-title":"Molecular genetics of HBV infection","volume":"15","author":"Locarnini","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bjid.2015.12.006_bib0235","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.antiviral.2009.12.006","article-title":"Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-na\u00efve Chinese patients","volume":"85","author":"Liu","year":"2010","journal-title":"Antivir Res"},{"key":"10.1016\/j.bjid.2015.12.006_bib0240","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/j.1365-2893.2011.01435.x","article-title":"Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B","volume":"18","author":"Mirandola","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bjid.2015.12.006_bib0245","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1365-2036.2009.04151.x","article-title":"Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B","volume":"30","author":"Nguyen","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bjid.2015.12.006_bib0250","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/135965350901400504","article-title":"Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients","volume":"14","author":"Pollicino","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bjid.2015.12.006_bib0255","doi-asserted-by":"crossref","first-page":"e35052","DOI":"10.1371\/journal.pone.0035052","article-title":"Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing","volume":"7","author":"Nishijima","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bjid.2015.12.006_bib0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000323521","article-title":"Antiviral resistance mutations and genotype associated amino acid substitutions in treatment-naive hepatitis B virus-infected individuals from the Indian subcontinent","volume":"55","author":"Ismail","year":"2012","journal-title":"Intervirology"},{"key":"10.1016\/j.bjid.2015.12.006_bib0265","first-page":"1440","article-title":"YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay","volume":"21","author":"Akarsu","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2015.12.006_bib0270","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jmv.23448","article-title":"Severe acute hepatitis B in a treatment-na\u00efve patients with antiviral drug resistant mutations in the polymerase gene","volume":"85","author":"Filippo","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.bjid.2015.12.006_bib0275","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/jmv.23948","article-title":"Amino acid polymorphism in the reverse transcriptase region of hepatitis B virus and the relationship with nucleos(t)ide analogues treatment for preventing mother-to-infant transmission","volume":"86","author":"Chen","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.bjid.2015.12.006_bib0280","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1099\/jgv.0.000010","article-title":"Nucleotide analogue-resistant mutations in hepatitis B viral genomes found in hepatitis B patients","volume":"96","author":"Fan","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bjid.2015.12.006_bib0285","first-page":"628","article-title":"Investigation of baseline antiviral resistance in treatment-na\u00efve chronic hepatitis B cases","volume":"47","author":"Koray","year":"2013","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.bjid.2015.12.006_bib0290","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3851\/IMP2938","article-title":"HBV carrying drug-resistance mutations in chronically infected treatment-na\u00efve patients","volume":"20","author":"Gomes-Gouvea","year":"2015","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bjid.2015.12.006_bib0295","doi-asserted-by":"crossref","first-page":"e0117429","DOI":"10.1371\/journal.pone.0117429","article-title":"Pre-existing mutations in reverse transcriptase of hepatitis B virus in treatment-na\u00efve Chinese patients with chronic hepatitis B","volume":"10","author":"Xu","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bjid.2015.12.006_bib0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-3527(08)60298-5","article-title":"Naturally occurring variants of hepatitis B virus","volume":"52","author":"Gunther","year":"1999","journal-title":"Adv Virus Res"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S141386701630023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S141386701630023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T02:54:32Z","timestamp":1654311272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S141386701630023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S141386701630023X"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2015.12.006","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2015.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}